MONOAMINEOXIDASE INHIBITION AND INSULIN SENSITIVITY

in Journal of Endocrinology
Author:
P. I. ADNITT
Search for other papers by P. I. ADNITT in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

SUMMARY

Insulin sensitivity was increased in rats treated for 21 days with mebanazine, 10mg./kg., phenelzine, 30mg./kg., or tranylcypromine, 10 mg./kg. but not in rats treated with isonicotinic acid hydrazide, 10 mg./kg., for 21 days or in animals treated with a single injection of mebanazine, 10 mg./kg. Pargyline, 14 mg./kg., given for 21 days produced 83% inhibition of hepatic monoamineoxidase and had a hypoglycaemic action when compared with 0·15 mg. mebanazine/kg., a dose just less than that required to inhibit monoamineoxidase. Increased insulin sensitivity seemed to be related to chronic inhibition of monoamineoxidase rather than to administration of hydrazine derivatives.

There was a tendency to anorexia during the drug treatment, but rats treated with monoamineoxidase inhibitors gained less weight than pair-fed control animals. This could be due to the previously reported reduction in growth hormone activity during treatment with monoamineoxidase inhibitors; nevertheless, any explanation for the increase in insulin sensitivity should be based upon the monoamineoxidase-inhibiting action of these drugs.

 

  • Collapse
  • Expand